Package 69367-351-60

Brand: lacosamide

Generic: lacosamide
NDC Package

Package Facts

Identity

Package NDC 69367-351-60
Digits Only 6936735160
Product NDC 69367-351
Product ID 69367-351_600757f7-b2e8-4c8e-aaf6-c468d7ada9a5
Description

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69367-351-60)

Marketing

Marketing Status
Marketed Since 2023-07-10
Brand lacosamide
Generic lacosamide
Sample Package No

Linked Drug Pages (1)

Lacosamide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "600757f7-b2e8-4c8e-aaf6-c468d7ada9a5", "openfda": {"nui": ["N0000008486"], "upc": ["0369367351607", "0369367350600", "0369367348607", "0369367349604"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69367-351-60)", "package_ndc": "69367-351-60", "marketing_start_date": "20230710"}], "brand_name": "Lacosamide", "product_id": "69367-351_600757f7-b2e8-4c8e-aaf6-c468d7ada9a5", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69367-351", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "200 mg/1"}], "application_number": "ANDA205237", "marketing_category": "ANDA", "marketing_start_date": "20230710", "listing_expiration_date": "20271231"}